Related Experiment Video
Updated: Jul 25, 2026

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
Published on: July 3, 2014
Extracellular Vesicles from Poor-Outcome Intracerebral Hemorrhage Patients Reveal Limited Reparative Potential in a
Fernando Laso-García1,2, Nerea Díaz-Gamero1, Rebeca Gallego-Ruiz1
1Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology and Stroke Centre, Neurology and Cerebrovascular Disease Group, Neuroscience Area, Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital-Universidad Autónoma de Madrid), Paseo de la Castellana, 261, 28046 Madrid, Spain.
Extracellular vesicles (EVs) from poor-outcome intracerebral hemorrhage (ICH) patients did not improve recovery in a rat model. These EVs did not reduce lesion volume or enhance motor function, indicating limited therapeutic potential.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Biomarker Discovery
Background:
- Extracellular vesicles (EVs) are investigated as therapeutics for neurological disorders.
- EVs from intracerebral hemorrhage (ICH) patients may serve as biomarkers for injury and repair.
- EVs from patients with favorable ICH outcomes show potential in preclinical models.
Purpose of the Study:
- To determine if intravenously administered EVs from poor-outcome ICH patients benefit a preclinical ICH model.
- To assess the impact of these EVs on lesion volume, functional recovery, and histological markers.
Main Methods:
- Intravenous administration of EVs from poor-outcome ICH patients in a rat ICH model.
- Evaluation of lesion volume at 24 hours, 72 hours, and 28 days post-ICH.
- Functional motor assessments using Rogers and tapered beam walking tests.
- Histological analysis of myelin preservation, astroglial activation, and angiogenesis markers at 28 days.
Main Results:
- No significant differences in lesion volume were observed between placebo and treatment groups.
- No improvement in motor function was detected in the treatment group across all assessment time points.
- Histological analysis revealed no significant differences in markers of myelin, glial activation, or angiogenesis.
Conclusions:
- EVs derived from poor-outcome ICH patients did not promote functional recovery in a rat ICH model.
- These EVs did not modulate key markers of injury and repair.
- The findings suggest limited endogenous repair mechanisms activated by these specific EVs.

